Immunoglobulin G fragment C receptor polymorphisms and response to trastuzumab-based treatment in patients with HER-2/neu-positive metastatic breast cancer

被引:0
|
作者
Musolino, A. [1 ]
Naldi, N. [1 ]
Bortesi, B. [1 ]
Capelletti, M. [1 ]
Pezzuolo, D. [1 ]
Michiara, M. [1 ]
Missale, G. [1 ]
Laccabue, D. [1 ]
Zerbini, A. [1 ]
Camisa, R. [1 ]
Ardizzoni, A. [1 ]
机构
[1] Univ Hosp Parma, Parma, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:119 / 120
页数:2
相关论文
共 50 条
  • [1] Immunoglobulin G fragment C receptor polymorphisms and response to trastuzumab-based treatment in patients with HER-2/NEU-positive metastatic breast cancer
    Musolino, A.
    Naldi, N.
    Bortesi, B.
    Capelletti, M.
    Pezzuolo, D.
    Franciosi, D.
    Missale, G.
    Laccabue, D.
    Camisa, R.
    Ardizzoni, A.
    ANNALS OF ONCOLOGY, 2006, 17 : XI17 - XI17
  • [2] Immunoglobulin G fragment C receptor polymorphisms and response to trastuzumab-based treatment in patients with HER-2/neu-positive metastatic breast cancer.
    Musolino, A.
    Naldi, N.
    Bortesi, B.
    Capelletti, M.
    Pezzuolo, D.
    Michiara, M.
    Missale, G.
    Loccabue, D.
    Zerbini, A.
    Camisa, R.
    Ardizzoni, A.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S170 - S170
  • [3] Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer
    Musolino, Antonino
    Naldi, Nadia
    Bortesi, Beatrice
    Pezzuolo, Debora
    Capelletti, Marzia
    Missale, Gabriele
    Laccabue, Diletta
    Zerbini, Alessandro
    Camisa, Roberta
    Bisagni, Giancarlo
    Neri, Tauro Maria
    Ardizzoni, Andrea
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (11) : 1789 - 1796
  • [4] Immunoglobulin G fragment C receptor polymorphisms and response to trastuzumab-based treatment in patients with HER-2/neupositive metastatic breast cancer
    Musolino, Antonino
    Naldi, Nadia
    Bortesi, Beatrice
    Capelletti, Marzia
    Pezzuolo, Debora
    Franciosi, Vittorio
    Missale, Gabriele
    Laccabue, Diletta
    Camisa, Roberta
    Ardizzoni, Andrea
    ANNALS OF ONCOLOGY, 2006, 17 : 245 - 245
  • [5] Adjuvant therapy with trastuzumab for HER-2/neu-positive breast cancer
    Gonzalez-Angulo, Ana M.
    Hortobagyi, Gabriel N.
    Esteva, Francisco J.
    ONCOLOGIST, 2006, 11 (08): : 857 - 867
  • [6] Multiple Subtypes of HER-2/Neu-Positive Metastatic Breast Cancer
    Lipton, A.
    Leitzel, K.
    Koestler, W.
    Fuchs, E-M
    Singer, C. F.
    Ali, S. M.
    Huang, W.
    Sperinde, J.
    Goodman, L.
    Jin, X.
    Barerjee, J.
    Weston, J.
    Mukherjee, A.
    Larson, J.
    Weidler, J.
    Paquet, A.
    Williams, S.
    Winslow, J.
    Parry, G.
    Bates, M.
    CANCER RESEARCH, 2009, 69 (24) : 601S - 602S
  • [7] Serum HER-2/neu and relative resistance to trastuzumab-based therapy in patients with metastatic breast cancer
    Ali, Suhail M.
    Carney, Walter P.
    Esteva, Francisco J.
    Fornier, Monica
    Harris, Lyndsay
    Koestler, Wolfgang. J.
    Lotz, Jean-Pierre
    Luftner, Diana
    Pichon, Marie-France
    Lipton, Allan
    CANCER, 2008, 113 (06) : 1294 - 1301
  • [8] Evaluation of Prognostic Factors and Trastuzumab-based Treatments in HER2/Neu-positive Metastatic Gastric Cancer
    Dogan, Izzet
    Karabulut, Senem
    Tastekin, Didem
    Ferhatoglu, Ferhat
    Paksoy, Nail
    Sakar, Burak
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (08): : 1014 - 1019
  • [9] Monitoring of serum Her-2/neu predicts response and progression-free survival to trastuzumab-based treatment in patients with metastatic breast cancer
    Köstler, WJ
    Schwab, B
    Singer, CF
    Neumann, R
    Rücklinger, E
    Brodowicz, T
    Tomek, S
    Niedermayr, M
    Hejna, M
    Steger, GG
    Krainer, M
    Wiltschke, C
    Zielinski, CC
    CLINICAL CANCER RESEARCH, 2004, 10 (05) : 1618 - 1624
  • [10] TRASTUZUMAB BEYOND PROGRESSION IN PATIENTS WITH HER-2/NEU POSITIVE METASTATIC BREAST CANCER
    Eralp, Yesim
    JOURNAL OF BREAST HEALTH, 2009, 5 (01): : 3 - 8